Home » Healthcare » Mesoporous Silica Nanoparticles Drugs Market

Mesoporous Silica Nanoparticles Drugs Market By End-user (Pharmaceutical company, Biotechnology companies, Academic and research institutions, Others) By Type (Small molecules, Proteins, Peptides, Nucleic acids, Others)-Growth, Future Prospects & Competitive Analysis, 2016 – 2030

Summary
Table Of Content

Key Highlights of the Report

The global mesoporous silica nanoparticles drugs market is segmented by end-user, type, applications, and region. Pharmaceutical company is the most popular end-user segment, while small molecules are the type segment leading market. Cancer therapy is the applications segment, with Asia-pacific leading the market growth.

The global mesoporous silica nanoparticles drugs market has been driven by several factors, including the rising prevalence of chronic diseases such as cancer and cardiovascular disorders & growing emphasis on personalized medicine and precision therapeutics. However, the market also faces significant challenges, including a lack of standardized manufacturing processes for MSN drugs, leading to inconsistencies in product quality and scalability & competition from alternative drug delivery systems, and the need for extensive clinical trials to demonstrate efficacy.

Nonetheless, the global mesoporous silica nanoparticles drugs market offers significant growth opportunities, such as increasing focus on personalized medicine and targeted therapies & advancements in nanotechnology and material science provide scope for the development of innovative MSN formulations with improved properties.

What Are the Main Drivers Of The Global Mesoporous silica nanoparticles drugs Market?

The global Mesoporous silica nanoparticles drugs market is driven by several factors, including rising prevalence of chronic diseases such as cancer and cardiovascular disorders & growing emphasis on personalized medicine and precision therapeutics.

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

What Are the Major Challenges Faced by The Global Mesoporous silica nanoparticles drugs Market?

The global Mesoporous silica nanoparticles drugs market also faces several challenges, such as a lack of standardized manufacturing processes for MSN drugs, leading to inconsistencies in product quality and scalability & competition from alternative drug delivery systems, and the need for extensive clinical trials for demonstrating efficacy.

What Are the Growth Opportunities in The Global Mesoporous silica nanoparticles drugs market?

The global Mesoporous silica nanoparticles drugs market offers significant growth opportunities, such as increasing focus on personalized medicine and targeted therapies & advancements in nanotechnology and material science provide scope for the development of innovative MSN formulations with improved properties.

Executive Summary

Overview of the Global Mesoporous silica nanoparticles drugs market

The global Mesoporous silica nanoparticles drugs market has been steadily growing in recent years due to rising prevalence of chronic diseases such as cancer and cardiovascular disorders & growing emphasis on personalized medicine and precision therapeutics. The market is characterized by a wide range of equipment, designs, and sizes, catering to diverse consumer preferences.

Market Definition

The global mesoporous silica nanoparticles (MSN) drugs market refers to the market for drugs that utilize mesoporous silica nanoparticles as carriers for targeted drug delivery. Mesoporous silica nanoparticles are nanoscale materials with well-defined pore structures that can encapsulate and deliver therapeutic agents to specific sites in the body. They offer advantages like controlled release, enhanced bioavailability, and improved therapeutic outcomes. The global market encompasses the production, development, and commercialization of MSN-based drugs for various medical applications, including cancer treatment, infectious diseases, and neurodegenerative disorders. It involves pharmaceutical companies, research institutions, regulatory bodies, and healthcare providers contributing to the growth and advancement of MSN drug technologies.

Market Insights

The global demand for mesoporous silica nanoparticles drugs was valued at USD XX Billion in 2022 and is expected to reach USD XX Billion in 2030, growing at a CAGR of 8.90% between 2023 and 2030.
The pharmaceutical companies are the leading end-user base segment and held more than three-firth of the share in terms of value in 2022, while the biotechnology companies & others segment is likely to exhibit the fastest CAGR during the forecast period.
Cancer therapy is the leading application-based segment expected to post the highest CAGR during the forecast period & leading the market share with more than 35% share in 2022.
Small molecules are the most demanded type segment that is expected to rise with maximum CAGR with nearly two-thirds of the share
Asia-pacific is fueling the growth of the Mesoporous silica nanoparticles drugs industry with nearly two-thirds share in 2022, while Europe and North America collectively accounted for just nearly 55% share in 2022. Europe held more than 30% share in 2022.

The major driver that drives the market is the rising prevalence of chronic diseases such as cancer and cardiovascular disorders & growing emphasis on personalized medicine and precision therapeutics.
At the same time, stringent regulatory requirements for the approval of novel drug delivery systems & high cost associated with the development and production of MSN drugs limits their accessibility are the main restraints.
Rising focus on personalized medicine and targeted therapies & advancements in nanotechnology and material science provide scope for the development of innovative MSN formulations with improved properties as the major opportunities in the market.

Market Overview

The global Mesoporous silica nanoparticles drugs market has witnessed steady growth in recent years and is expected to grow at a CAGR of 8.90% between 2023 and 2030. The market was valued at USD XX billion in 2022 and is expected to reach USD XX billion in 2030.

Segmentation by the End-user

Pharmaceutical company type is the leading segment and holds more than three-firth of the share in terms of value.

Biotechnology companies & others will likely exhibit the fastest CAGR during the forecast period.

Segmentation by Type

Small molecules end user is the leading segment and holds more than two-thirds of the share in terms of value.
Proteins & others contribute to the rest of the demand for the mesoporous silica nanoparticles drugs market.

Segmentation by Applications

Cancer therapy segment governs the demand for the mesoporous silica nanoparticles drugs industry in the world, holding held more than 35% share in 2022
Cardiovascular disease contributes to the rest of the demand for mesoporous silica nanoparticles drugs market.

Segmentation by Region

Asia-pacific was fueling the growth of the Mesoporous silica nanoparticles drugs industry with a nearly two-third share in 2022.
North America and Europe collectively account for nearly under 55% share in 2022, with Europe held more than 30% share in 2022.
The rest of the world, including Latin America, The Middle East, and Africa, contributes the remainder to the demand for mesoporous silica nanoparticles drugs.

France has a strong research and development infrastructure, with renowned universities and research institutes focusing on nanotechnology and drug delivery systems. This creates a conducive environment for the development of MSN-based drugs. Additionally, the French government has been supportive of innovation and investment in the healthcare sector, providing funding and incentives for research and development activities. The country also has a robust pharmaceutical industry and a well-established healthcare system, which facilitates the translation of research findings into commercial products. Furthermore, collaborations between academia, industry, and government organizations in France foster knowledge exchange and accelerate the development and commercialization of MSN drugs.

China has made significant investments in research and development, particularly in the field of nanotechnology and pharmaceuticals. This has resulted in the establishment of world-class research institutes and academic collaborations that have advanced MSN drug technologies. Additionally, the Chinese government has implemented favorable policies and regulations to support the development and commercialization of innovative drugs, including MSN-based formulations. Moreover, China has a large population with a high burden of diseases such as cancer, creating a strong demand for advanced drug delivery systems like MSN drugs.

Market Drivers

Several factors drive the global mesoporous silica nanoparticles drugs market. The following are the key drivers of the global Mesoporous silica nanoparticles drugs market:

Advancements in Targeted Drug Delivery

Mesoporous silica nanoparticles (MSN) offer a unique advantage of controlled and site-specific drug release, enhancing therapeutic outcomes and reducing side effects. For example, researchers at Zhejiang University in China developed a mesoporous silica nanoparticle-based drug delivery system for targeted cancer therapy. The system utilized MSN carriers loaded with chemotherapy drugs, which selectively accumulated in tumor tissues, resulting in improved efficacy and reduced toxicity compared to conventional drug delivery methods.

Rising Emphasis on Personalized Medicine

The increasing emphasis on personalized medicine is another driver of the MSN drugs industry. MSN nanoparticles allow for precise drug targeting, making them suitable for personalized treatment approaches. For instance, researchers at the University of California, Los Angeles (UCLA) developed MSN-based drug delivery systems that could be tailored for individual patients. These systems enabled the delivery of multiple drugs simultaneously, customized for specific disease conditions and patient characteristics, leading to personalized therapeutic strategies.

Market Restraints

The global mesoporous silica nanoparticles drugs market faces some challenges that may hinder its growth. These include the following:

Stringent regulatory requirements

Stringent regulatory requirements for the approval of novel drug delivery systems are the major restraint of mesoporous silica nanoparticles drugs market. The complex regulatory landscape can pose challenges and delays in bringing MSN drugs to market. Regulatory agencies worldwide have differing requirements and standards for the approval of nanomedicine products, including MSN drugs. This lack of harmonization in regulatory guidelines can create additional barriers and complexities for companies seeking global market access for their MSN drug products.

For instance, the U.S. Food and Drug Administration (FDA) issued a draft guidance on the characterization and testing of MSN-based drug products. The guidance outlined the regulatory expectations for the development, manufacturing, and approval of MSN drugs.

Opportunities

The global mesoporous silica nanoparticles drugs market offers significant growth opportunities. These include the following:

Expanding applications beyond cancer treatment

The unique properties of MSN nanoparticles, such as their large surface area and tunable pore size, make them attractive for applications in neurodegenerative disorders. Researchers are exploring the potential of MSN-based formulations to deliver neuroprotective agents, gene therapy vectors, or imaging agents specifically to affected brain regions in diseases like Alzheimer’s or Parkinson’s. MSN nanoparticles can be functionalized and tailored to carry various therapeutic agents, including small molecules, proteins, and nucleic acids.

Competitive Landscape

Key Players

The global Mesoporous silica nanoparticles drugs market is highly competitive, with the presence of several key players. Some of the major players in the market and their market share are as follows:

Agilent Technologies, Inc.
Bio-Rad Laboratories
FUJIFILM Wako Pure Chemical Corporation
Merck KGaA
Novo Nordisk A/S
Shimadzu Corporation
Sigma-Aldrich Corporation
Suzhou Pole-Star Polymer Material Co., Ltd.
Thermo Fisher Scientific and Waters Corporation

These companies focus on product innovation, expanding their applications, mergers, and acquisitions to stay ahead in the market.

The major players in the global Mesoporous silica nanoparticles drugs market constantly strive to stay ahead by introducing new products and innovations.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

Summary of Key Findings

Rising prevalence of chronic diseases such as cancer and cardiovascular disorders & growing emphasis on personalized medicine and precision therapeutics driving market growth

Market segmented by end-user, type, applications, and region.
A pharmaceutical company is the most popular application segment, with biotechnology companies & other end users as the primary type segment.
Small molecules are the most common type of segment.

Cancer therapy segment governs the demand for the mesoporous silica nanoparticles drugs industry
Asia-pacific is leading market growth; the market is highly competitive with key players including Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., FUJIFILM Wako Pure Chemical Corporation, Merck KGaA, Novo Nordisk A/S, Shimadzu Corporation, Sigma-Aldrich Corporation, Suzhou Pole-Star Polymer Material Co., Ltd., and others.

Future Outlook

Positive outlook for the global mesoporous silica nanoparticles drugs market with significant growth potential in the Europe region

Growing prevalence of chronic diseases such as cancer and cardiovascular disorders & growing emphasis on personalized medicine and precision therapeutics drive growth

Challenges facing the mesoporous silica nanoparticles drugs market is the lack of standardized manufacturing processes for MSN drugs, leading to inconsistencies in product quality and scalability & competition from alternative drug delivery systems, and the need for extensive clinical trials for demonstrate efficacy.

Segmentation

By End-user
- Pharmaceutical company
- Biotechnology companies
- Academic and research institutions
- Others
By Type
- Small molecules
- Proteins
- Peptides
- Nucleic acids
- Others
By Application
- Cardiovascular disease
- Cancer therapy
- Neurological disorders
- Others
By Region

North America
- US
- Canada
- Mexico
Europe
- Germany
- France
- The U.K.
- Italy
- Spain
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- South-east Asia
- Rest of Asia Pacific
Latin America
- Brazil
- Argentina
- Rest of Latin America
Middle East & Africa
- GCC Countries
- South Africa
- Rest of the Middle East and Africa

1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Data Modelling
1.3.2.1. Company Share Analysis Model
1.3.2.2. Revenue Based Modelling
1.3.3. Phase III – Primary Research
1.3.4. Research Limitations
1.3.5. Assumptions
1.4. Market Introduction
1.5. Market Research Scope

2. Executive Summary
2.1. Market Snapshot: Global Mesoporous silica nanoparticles drugs Market
2.2. Global Mesoporous silica nanoparticles drugs Market, By End-user
2.3. Global Mesoporous silica nanoparticles drugs Market, By Type
2.4. Global Mesoporous silica nanoparticles drugs Market, By Application
2.5. Global Mesoporous silica nanoparticles drugs Market, By Region

3. Market Dynamics & Factors Analysis
3.1. Introduction
3.1.1. Global Mesoporous silica nanoparticles drugs Market Value, 2017-2030, (US$ Bn)
3.1.2. Y-o-Y Growth Trend Analysis
3.2. Market Dynamics
3.2.1. Market Drivers
3.2.2. Market Restraints
3.2.3. Market Opportunities
3.2.4. Major Industry Challenges
3.3. Growth and Development Patterns
3.4. Investment Feasibility Analysis
3.5. Market Opportunity Analysis
3.5.1. End-user
3.5.2. Type
3.5.3. Application
3.5.4. Geography

4. Premium Insights
4.1. STAR (Situation, Task, Action, Results) Analysis
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers/Consumers
4.2.3. Bargaining Power of Suppliers
4.2.4. Threat of Substitute Types
4.2.5. Intensity of Competitive Rivalry
4.3. Key Market Trends
4.3.1. Demand Side Trends
4.3.2. Supply Side Trends
4.4. Value Chain Analysis
4.5. Technology Analysis
4.6. Analysis and Recommendations
4.7. Marketing Strategy Analysis
4.7.1. Direct Marketing
4.7.2. Indirect Marketing
4.7.3. Marketing Channel Development Trend

5. Market Positioning of Key Players, 2022
5.1. Company market share of key players, 2022
5.2. Competitive Benchmarking
5.3. Market Positioning of Key Vendors
5.4. Geographical Presence Analysis
5.5. Major Strategies Adopted by Key Players
5.5.1. Key Strategies Analysis
5.5.2. Mergers and Acquisitions
5.5.3. Partnerships
5.5.4. Product Launch
5.5.5. Geographical Expansion
5.5.6. Others

6. Economic Impact Analysis
6.1. Recession Impact
6.1.1. North America
6.1.2. Europe
6.1.3. Asia Pacific
6.1.4. Latin America
6.1.5. Middle East and Africa
6.2. Ukraine-Russia War Impact
6.2.1. North America
6.2.2. Europe
6.2.3. Asia Pacific
6.2.4. Latin America
6.2.5. Middle East and Africa
6.3. COVID-19 Impact Analysis
6.3.1. North America
6.3.2. Europe
6.3.3. Asia Pacific
6.3.4. Latin America
6.3.5. Middle East and Africa

7. Global Mesoporous silica nanoparticles drugs Market, By End-user
7.1. Global Mesoporous silica nanoparticles drugs Market Overview, by End-user
7.1.1. Global Mesoporous silica nanoparticles drugs Market Revenue Share, By End-user, 2022 Vs 2030 (in %)
7.2. Pharmaceutical Company
7.2.1. Global Mesoporous silica nanoparticles drugs Market, By Region, 2017-2030 (US$ Bn)
7.3. Biotechnology companies
7.3.1. Global Mesoporous silica nanoparticles drugs Market, By Region, 2017-2030 (US$ Bn)
7.4. Academic and research institutions
7.4.1. Global Mesoporous silica nanoparticles drugs Market, By Region, 2017-2030 (US$ Bn)
7.5. Others
7.5.1. Global Mesoporous silica nanoparticles drugs Market, By Region, 2017-2030 (US$ Bn)

8. Global Mesoporous silica nanoparticles drugs Market, by Type, 2017-2030 (US$ Bn)
8.1. Global Mesoporous silica nanoparticles drugs Market Overview, by Type
8.1.1. Global Mesoporous silica nanoparticles drugs Market, By Type, 2022 vs 2030 (in%)
8.2. Small molecules
8.2.1. Global Mesoporous silica nanoparticles drugs Market, By Region, 2017-2030 (US$ Bn)
8.3. Peptides
8.3.1. Global Mesoporous silica nanoparticles drugs Market, By Region, 2017-2030 (US$ Bn)
8.4. Proteins
8.4.1. Global Mesoporous silica nanoparticles drugs Market, By Region, 2017-2030 (US$ Bn)
8.5. Nucleic acids
8.5.1. Global Mesoporous silica nanoparticles drugs Market, By Region, 2017-2030 (US$ Bn)
8.6. Others
8.6.1. Global Mesoporous silica nanoparticles drugs Market, By Region, 2017-2030 (US$ Bn)

9. Global Mesoporous silica nanoparticles drugs Market, By Application
9.1. Global Mesoporous silica nanoparticles drugs Market Overview, by Application
9.1.1. Global Mesoporous silica nanoparticles drugs Market, By Application, 2022 vs 2030 (in %)
9.2. Cancer therapy
9.2.1. Global Mesoporous silica nanoparticles drugs Market, By Region, 2017-2030 (US$ Bn)
9.3. Cardiovascular disease
9.3.1. Global Mesoporous silica nanoparticles drugs Market, By Region, 2017-2030 (US$ Bn)
9.4. Neurological disorders
9.4.1. Global Mesoporous silica nanoparticles drugs Market, By Region, 2017-2030 (US$ Bn)
9.5. Others
9.5.1. Global Mesoporous silica nanoparticles drugs Market, By Region, 2017-2030 (US$ Bn)

10. Global Mesoporous silica nanoparticles drugs Market, By Region
10.1. Global Mesoporous silica nanoparticles drugs Market Overview, by Region
10.1.1. Global Mesoporous silica nanoparticles drugs Market, By Region, 2022 vs 2030 (in%)
10.2. End-user
10.2.1. Global Mesoporous silica nanoparticles drugs Market, By End-user, 2017-2030 (US$ Bn)
10.3. Type
10.3.1. Global Mesoporous silica nanoparticles drugs Market, By Type, 2017-2030 (US$ Bn)
10.4. Application
10.4.1. Global Mesoporous silica nanoparticles drugs Market, By Application, 2017-2030 (US$ Bn)

11. North America Mesoporous silica nanoparticles drugs Market Analysis
11.1. North America Mesoporous silica nanoparticles drugs Market, by End-user, 2017-2030(US$ Bn)
11.1.1. Overview
11.1.2. SRC Analysis
11.2. North America Mesoporous silica nanoparticles drugs Market, by Type, 2017-2030(US$ Bn)
11.2.1. Overview
11.2.2. SRC Analysis
11.3. North America Mesoporous silica nanoparticles drugs Market, by Application, 2017-2030(US$ Bn)
11.3.1. Overview
11.3.2. SRC Analysis
11.4. North America Mesoporous silica nanoparticles drugs Market, by Country, 2017-2030 (US$ Bn)
11.4.1. North America Mesoporous silica nanoparticles drugs Market, by Country, 2022 Vs 2030 (in%)
11.4.2. U.S.
11.4.2.1. U.S. Mesoporous silica nanoparticles drugs Market Estimates and Forecast, 2017-2030 (US$ Bn)
11.4.2.2. U.S. Mesoporous silica nanoparticles drugs, By End-user, 2017-2030 (US$ Bn)
11.4.2.3. U.S. Mesoporous silica nanoparticles drugs, By Type, 2017-2030 (US$ Bn)
11.4.2.4. U.S. Mesoporous silica nanoparticles drugs, By Application, 2017-2030 (US$ Bn)
11.4.3. Canada
11.4.3.1. Canada Mesoporous silica nanoparticles drugs Market Estimates and Forecast, 2017-2030 (US$ Bn)
11.4.3.2. Canada Mesoporous silica nanoparticles drugs, By End-user, 2017-2030 (US$ Bn)
11.4.3.3. Canada Mesoporous silica nanoparticles drugs, By Type, 2017-2030 (US$ Bn)
11.4.3.4. Canada Mesoporous silica nanoparticles drugs, By Application, 2017-2030 (US$ Bn)
11.4.4. Mexico
11.4.4.1. Mexico Mesoporous silica nanoparticles drugs Market Estimates and Forecast, 2017-2030 (US$ Bn)
11.4.4.2. Mexico Mesoporous silica nanoparticles drugs, By End-user, 2017-2030 (US$ Bn)
11.4.4.3. Mexico Mesoporous silica nanoparticles drugs, By Type, 2017-2030 (US$ Bn)
11.4.4.4. Mexico Mesoporous silica nanoparticles drugs, By Application, 2017-2030 (US$ Bn)

12. Europe Mesoporous silica nanoparticles drugs Market Analysis
12.1. Europe Mesoporous silica nanoparticles drugs Market, by End-user, 2017-2030(US$ Bn)
12.1.1. Overview
12.1.2. SRC Analysis
12.2. Europe Mesoporous silica nanoparticles drugs Market, by Type, 2017-2030(US$ Bn)
12.2.1. Overview
12.2.2. SRC Analysis
12.3. Europe Mesoporous silica nanoparticles drugs Market, by Application, 2017-2030(US$ Bn)
12.3.1. Overview
12.3.2. SRC Analysis
12.4. Europe Mesoporous silica nanoparticles drugs Market, by region, 2017-2030 (US$ Bn)
12.4.1. Europe Mesoporous silica nanoparticles drugs Market, by Country, 2022 Vs 2030 (in%)
12.4.2. Germany
12.4.2.1. Germany Mesoporous silica nanoparticles drugs Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.4.2.2. Germany Mesoporous silica nanoparticles drugs, By End-user, 2017-2030 (US$ Bn)
12.4.2.3. Germany Mesoporous silica nanoparticles drugs, By Type, 2017-2030 (US$ Bn)
12.4.2.4. Germany Mesoporous silica nanoparticles drugs, By Application, 2017-2030 (US$ Bn)
12.4.3. France
12.4.3.1. France Mesoporous silica nanoparticles drugs Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.4.3.2. France Mesoporous silica nanoparticles drugs, By End-user, 2017-2030 (US$ Bn)
12.4.3.3. France Mesoporous silica nanoparticles drugs, By Type, 2017-2030 (US$ Bn)
12.4.3.4. France Mesoporous silica nanoparticles drugs, By Application, 2017-2030 (US$ Bn)
12.4.4. UK
12.4.4.1. UK Mesoporous silica nanoparticles drugs Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.4.4.2. UK Mesoporous silica nanoparticles drugs, By End-user, 2017-2030 (US$ Bn)
12.4.4.3. UK Mesoporous silica nanoparticles drugs, By Type, 2017-2030 (US$ Bn)
12.4.4.4. UK Mesoporous silica nanoparticles drugs, By Application, 2017-2030 (US$ Bn)
12.4.5. Italy
12.4.5.1. Italy Mesoporous silica nanoparticles drugs Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.4.5.2. Italy Mesoporous silica nanoparticles drugs, By End-user, 2017-2030 (US$ Bn)
12.4.5.3. Italy Mesoporous silica nanoparticles drugs, By Type, 2017-2030 (US$ Bn)
12.4.5.4. Italy Mesoporous silica nanoparticles drugs, By Application, 2017-2030 (US$ Bn)
12.4.6. Spain
12.4.6.1. Spain Mesoporous silica nanoparticles drugs Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.4.6.2. Spain Mesoporous silica nanoparticles drugs, By End-user, 2017-2030 (US$ Bn)
12.4.6.3. Spain Mesoporous silica nanoparticles drugs, By Type, 2017-2030 (US$ Bn)
12.4.6.4. Spain Mesoporous silica nanoparticles drugs, By Application, 2017-2030 (US$ Bn)
12.4.7. Rest of Europe
12.4.7.1. Rest of Europe Mesoporous silica nanoparticles drugs Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.4.7.2. Rest of Europe Mesoporous silica nanoparticles drugs, By End-user, 2017-2030 (US$ Bn)
12.4.7.3. Rest of Europe Mesoporous silica nanoparticles drugs, By Type, 2017-2030 (US$ Bn)
12.4.7.4. Rest of Europe Mesoporous silica nanoparticles drugs, By Application, 2017-2030 (US$ Bn)

13. Asia Pacific Mesoporous silica nanoparticles drugs Market Analysis
13.1. Asia Pacific Mesoporous silica nanoparticles drugs Market, by End-user, 2017-2030(US$ Bn)
13.1.1. Overview
13.1.2. SRC Analysis
13.2. Asia Pacific Mesoporous silica nanoparticles drugs Market, by Type, 2017-2030(US$ Bn)
13.2.1. Overview
13.2.2. SRC Analysis
13.3. Asia Pacific Mesoporous silica nanoparticles drugs Market, by Application, 2017-2030(US$ Bn)
13.3.1. Overview
13.3.2. SRC Analysis
13.4. Asia Pacific Mesoporous silica nanoparticles drugs Market, by Country, 2017-2030 (US$ Bn)
13.4.1. Asia Pacific Mesoporous silica nanoparticles drugs Market, by Country, 2022 Vs 2030 (in%)
13.4.2. China
13.4.2.1. China Mesoporous silica nanoparticles drugs Market Estimates and Forecast, 2017-2030 (US$ Bn)
13.4.2.2. China Mesoporous silica nanoparticles drugs, By End-user, 2017-2030 (US$ Bn)
13.4.2.3. China Mesoporous silica nanoparticles drugs, By Type, 2017-2030 (US$ Bn)
13.4.2.4. China Mesoporous silica nanoparticles drugs, By Application, 2017-2030 (US$ Bn)
13.4.3. Japan
13.4.3.1. Japan Mesoporous silica nanoparticles drugs Market Estimates and Forecast, 2017-2030 (US$ Bn)
13.4.3.2. Japan Mesoporous silica nanoparticles drugs, By End-user, 2017-2030 (US$ Bn)
13.4.3.3. Japan Mesoporous silica nanoparticles drugs, By Type, 2017-2030 (US$ Bn)
13.4.3.4. Japan Mesoporous silica nanoparticles drugs, By Application, 2017-2030 (US$ Bn)
13.4.4. India
13.4.4.1. India Mesoporous silica nanoparticles drugs Market Estimates and Forecast, 2017-2030 (US$ Bn)
13.4.4.2. India Mesoporous silica nanoparticles drugs, By End-user, 2017-2030 (US$ Bn)
13.4.4.3. India Mesoporous silica nanoparticles drugs, By Type, 2017-2030 (US$ Bn)
13.4.4.4. India Mesoporous silica nanoparticles drugs, By Application, 2017-2030 (US$ Bn)
13.4.5. South Korea
13.4.5.1. South Korea Mesoporous silica nanoparticles drugs Market Estimates and Forecast, 2017-2030 (US$ Bn)
13.4.5.2. South Korea Mesoporous silica nanoparticles drugs, By End-user, 2017-2030 (US$ Bn)
13.4.5.3. South Korea Mesoporous silica nanoparticles drugs, By Type, 2017-2030 (US$ Bn)
13.4.5.4. South Korea Mesoporous silica nanoparticles drugs, By Application, 2017-2030 (US$ Bn)
13.4.6. South-East Asia
13.4.6.1. South-East Asia Mesoporous silica nanoparticles drugs Market Estimates and Forecast, 2017-2030 (US$ Bn)
13.4.6.2. South-East Asia Mesoporous silica nanoparticles drugs, By End-user, 2017-2030 (US$ Bn)
13.4.6.3. South-East Asia Mesoporous silica nanoparticles drugs, By Type, 2017-2030 (US$ Bn)
13.4.6.4. South-East Asia Mesoporous silica nanoparticles drugs, By Application, 2017-2030 (US$ Bn)
13.4.7. Rest of Asia Pacific
13.4.7.1. Rest of Asia Pacific Mesoporous silica nanoparticles drugs Market Estimates and Forecast, 2017-2030 (US$ Bn)
13.4.7.2. Rest of Asia Pacific Mesoporous silica nanoparticles drugs, By End-user, 2017-2030 (US$ Bn)
13.4.7.3. Rest of Asia Pacific Mesoporous silica nanoparticles drugs, By Type, 2017-2030 (US$ Bn)
13.4.7.4. Rest of Asia Pacific Mesoporous silica nanoparticles drugs, By Application, 2017-2030 (US$ Bn)

14. Latin America Mesoporous silica nanoparticles drugs Market Analysis
14.1. Latin America Mesoporous silica nanoparticles drugs Market, by End-user, 2017-2030(US$ Bn)
14.1.1. Overview
14.1.2. SRC Analysis
14.2. Latin America Mesoporous silica nanoparticles drugs Market, by Type, 2017-2030(US$ Bn)
14.2.1. Overview
14.2.2. SRC Analysis
14.3. Latin America Mesoporous silica nanoparticles drugs Market, by Application, 2017-2030(US$ Bn)
14.3.1. Overview
14.3.2. SRC Analysis
14.4. Latin America Mesoporous silica nanoparticles drugs Market, by Country, 2017-2030 (US$ Bn)
14.4.1. Latin America Mesoporous silica nanoparticles drugs Market, by Country, 2022 Vs 2030 (in%)
14.4.2. Brazil
14.4.2.1. Brazil Mesoporous silica nanoparticles drugs Market Estimates and Forecast, 2017-2030 (US$ Bn)
14.4.2.2. Brazil Mesoporous silica nanoparticles drugs, By End-user, 2017-2030 (US$ Bn)
14.4.2.3. Brazil Mesoporous silica nanoparticles drugs, By Type, 2017-2030 (US$ Bn)
14.4.2.4. Brazil Mesoporous silica nanoparticles drugs, By Application, 2017-2030 (US$ Bn)
14.4.3. Argentina
14.4.3.1. Argentina Mesoporous silica nanoparticles drugs Market Estimates and Forecast, 2017-2030 (US$ Bn)
14.4.3.2. Argentina Mesoporous silica nanoparticles drugs, By End-user, 2017-2030 (US$ Bn)
14.4.3.3. Argentina Mesoporous silica nanoparticles drugs, By Type, 2017-2030 (US$ Bn)
14.4.3.4. Argentina Mesoporous silica nanoparticles drugs, By Application, 2017-2030 (US$ Bn)
14.4.4. Rest of Latin America
14.4.4.1. Rest of Latin America Mesoporous silica nanoparticles drugs Market Estimates and Forecast, 2017-2030 (US$ Bn)
14.4.4.2. Rest of Latin America Mesoporous silica nanoparticles drugs, By End-user, 2017-2030 (US$ Bn)
14.4.4.3. Rest of Latin America Mesoporous silica nanoparticles drugs, By Type, 2017-2030 (US$ Bn)
14.4.4.4. Rest of Latin America Mesoporous silica nanoparticles drugs, By Application, 2017-2030 (US$ Bn)

15. Middle East and Africa Mesoporous silica nanoparticles drugs Market Analysis
15.1. Middle East and Africa Mesoporous silica nanoparticles drugs Market, by End-user, 2017-2030(US$ Bn)
15.1.1. Overview
15.1.2. SRC Analysis
15.2. Middle East and Africa Mesoporous silica nanoparticles drugs Market, by Type, 2017-2030(US$ Bn)
15.2.1. Overview
15.2.2. SRC Analysis
15.3. Middle East and Africa Mesoporous silica nanoparticles drugs Market, by Application, 2017-2030(US$ Bn)
15.3.1. Overview
15.3.2. SRC Analysis
15.4. Middle East and Africa Mesoporous silica nanoparticles drugs Market, by Country, 2017-2030 (US$ Bn)
15.4.1. Middle East and Africa Mesoporous silica nanoparticles drugs Market, by Country, 2022 Vs 2030 (in%)
15.4.2. GCC Countries
15.4.2.1. GCC Countries Mesoporous silica nanoparticles drugs Market Estimates and Forecast, 2017-2030 (US$ Bn)
15.4.2.2. GCC Countries Mesoporous silica nanoparticles drugs, By End-user, 2017-2030 (US$ Bn)
15.4.2.3. GCC Countries Mesoporous silica nanoparticles drugs, By Type, 2017-2030 (US$ Bn)
15.4.2.4. GCC Countries Mesoporous silica nanoparticles drugs, By Application, 2017-2030 (US$ Bn)
15.4.3. South Africa
15.4.3.1. South Africa Mesoporous silica nanoparticles drugs Market Estimates and Forecast, 2017-2030 (US$ Bn)
15.4.3.2. South Africa Mesoporous silica nanoparticles drugs, By End-user, 2017-2030 (US$ Bn)
15.4.3.3. South Africa Mesoporous silica nanoparticles drugs, By Type, 2017-2030 (US$ Bn)
15.4.3.4. South Africa Mesoporous silica nanoparticles drugs, By Application, 2017-2030 (US$ Bn)
15.4.4. Rest of Middle East and Africa
15.4.4.1. Rest of Middle East and Africa Mesoporous silica nanoparticles drugs Market Estimates and Forecast, 2017-2030 (US$ Bn)
15.4.4.2. Rest of Middle East and Africa Mesoporous silica nanoparticles drugs, By End-user, 2017-2030 (US$ Bn)
15.4.4.3. Rest of Middle East and Africa Mesoporous silica nanoparticles drugs, By Type, 2017-2030 (US$ Bn)
15.4.4.4. Rest of Middle East and Africa Mesoporous silica nanoparticles drugs, By Application, 2017-2030 (US$ Bn)

16. Company Profiles
16.1. Agilent Technologies, Inc.
16.1.1. Company Overview
16.1.2. Deployments/Services Portfolio
16.1.3. Geographical Presence
16.1.4. Financial Summary
16.1.4.1. Market Revenue and Net Profit (2019-2022)
16.1.4.2. Business Segment Revenue Analysis
16.1.4.3. Geographical Revenue Analysis
16.2. Bio-Rad Laboratories, Inc.
16.3. FUJIFILM Wako Pure Chemical Corporation
16.4. Merck KGaA
16.5. Novo Nordisk A/S
16.6. Shimadzu Corporation
16.7. Sigma-Aldrich Corporation
16.8. Suzhou Pole-Star Polymer Material Co., Ltd.
16.9. Thermo Fisher Scientific
16.10. Waters Corporation

List of Figures
FIG. 1 Global Mesoporous silica nanoparticles drugs Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 Global Mesoporous silica nanoparticles drugs Market Segmentation
FIG. 4 Global Mesoporous silica nanoparticles drugs Market, by End-user, 2022 (US$ Bn)
FIG. 5 Global Mesoporous silica nanoparticles drugs Market, by Type, 2022 (US$ Bn)
FIG. 6 Global Mesoporous silica nanoparticles drugs Market, by Application, 2022 (US$ Bn)
FIG. 7 Global Mesoporous silica nanoparticles drugs Market, by Geography, 2022 (US$ Bn)
FIG. 8 Attractive Investment Proposition, by End-user, 2022
FIG. 9 Attractive Investment Proposition, by Type, 2022
FIG. 10 Attractive Investment Proposition, by Application, 2022
FIG. 11 Attractive Investment Proposition, by Geography, 2022
FIG. 12 Global Market Share Analysis of Key Mesoporous silica nanoparticles drugs Market Manufacturers, 2022
FIG. 13 Global Market Positioning of Key Mesoporous silica nanoparticles drugs Market Manufacturers, 2022
FIG. 14 Global Mesoporous silica nanoparticles drugs Market Value Contribution, By End-user, 2022 & 2030 (Value %)
FIG. 15 Global Mesoporous silica nanoparticles drugs Market, by Pharmaceutical Company, Value, 2017-2030 (US$ Bn)
FIG. 16 Global Mesoporous silica nanoparticles drugs Market, by Biotechnology companies, Value, 2017-2030 (US$ Bn)
FIG. 17 Global Mesoporous silica nanoparticles drugs Market, by Academic and research institutions, Value, 2017-2030 (US$ Bn)
FIG. 18 Global Mesoporous silica nanoparticles drugs Market, by Others, Value, 2017-2030 (US$ Bn)
FIG. 19 Global Mesoporous silica nanoparticles drugs Market Value Contribution, By Type, 2022 & 2030 (Value %)
FIG. 20 Global Mesoporous silica nanoparticles drugs Market, by Small molecules, Value, 2017-2030 (US$ Bn)
FIG. 21 Global Mesoporous silica nanoparticles drugs Market, by Peptides, 2017-2030 (US$ Bn)
FIG. 22 Global Mesoporous silica nanoparticles drugs Market, by Proteins, Value, 2017-2030 (US$ Bn)
FIG. 23 Global Mesoporous silica nanoparticles drugs Market, by Nucleic acids, 2017-2030 (US$ Bn)
FIG. 24 Global Mesoporous silica nanoparticles drugs Market, by Others (Essential Oils, Floral Flavours), Value, 2017-2030 (US$ Bn)
FIG. 25 Global Mesoporous silica nanoparticles drugs Market Value Contribution, By Application, 2022 & 2030 (Value %)
FIG. 26 Global Mesoporous silica nanoparticles drugs Market, by Cancer therapy, Value, 2017-2030 (US$ Bn)
FIG. 27 Global Mesoporous silica nanoparticles drugs Market, by Cardiovascular disease, Value, 2017-2030 (US$ Bn)
FIG. 28 Global Mesoporous silica nanoparticles drugs Market, by Neurological disorders, Value, 2017-2030 (US$ Bn)
FIG. 29 Global Mesoporous silica nanoparticles drugs Market, by Others, Value, 2017-2030 (US$ Bn)
FIG. 30 North America Mesoporous silica nanoparticles drugs Market, 2017-2030 (US$ Bn)
FIG. 31 U.S. Mesoporous silica nanoparticles drugs Market, 2017-2030 (US$ Bn)
FIG. 32 Canada Mesoporous silica nanoparticles drugs Market, 2017-2030 (US$ Bn)
FIG. 33 Europe Mesoporous silica nanoparticles drugs Market, 2017-2030 (US$ Bn)
FIG. 34 Germany Mesoporous silica nanoparticles drugs Market, 2017-2030 (US$ Bn)
FIG. 35 France Mesoporous silica nanoparticles drugs Market, 2017-2030 (US$ Bn)
FIG. 36 U.K. Mesoporous silica nanoparticles drugs Market, 2017-2030 (US$ Bn)
FIG. 37 Italy Mesoporous silica nanoparticles drugs Market, 2017-2030 (US$ Bn)
FIG. 38 Spain Mesoporous silica nanoparticles drugs Market, 2017-2030 (US$ Bn)
FIG. 39 Rest of Europe Mesoporous silica nanoparticles drugs Market, 2017-2030 (US$ Bn)
FIG. 40 Asia Pacific Mesoporous silica nanoparticles drugs Market, 2017-2030 (US$ Bn)
FIG. 41 China Mesoporous silica nanoparticles drugs Market, 2017-2030 (US$ Bn)
FIG. 42 Japan Mesoporous silica nanoparticles drugs Market, 2017-2030 (US$ Bn)
FIG. 43 India Mesoporous silica nanoparticles drugs Market, 2017-2030 (US$ Bn)
FIG. 44 South Korea Mesoporous silica nanoparticles drugs Market, 2017-2030 (US$ Bn)
FIG. 45 South-East Asia Mesoporous silica nanoparticles drugs Market, 2017-2030 (US$ Bn)
FIG. 46 Rest of Asia Pacific Mesoporous silica nanoparticles drugs Market, 2017-2030 (US$ Bn)
FIG. 47 Latin America Mesoporous silica nanoparticles drugs Market, 2017-2030 (US$ Bn)
FIG. 48 Brazil Mesoporous silica nanoparticles drugs Market, 2017-2030 (US$ Bn)
FIG. 49 Mexico Mesoporous silica nanoparticles drugs Market, 2017-2030 (US$ Bn)
FIG. 50 Rest of Latin America Mesoporous silica nanoparticles drugs Market, 2017-2030 (US$ Bn)
FIG. 51 Middle East & Africa Mesoporous silica nanoparticles drugs Market, 2017-2030 (US$ Bn)
FIG. 52 GCC Countries Mesoporous silica nanoparticles drugs Market, 2017-2030 (US$ Bn)
FIG. 53 South Africa Mesoporous silica nanoparticles drugs Market, 2017-2030 (US$ Bn)
FIG. 54 Rest of Middle East and Africa Mesoporous silica nanoparticles drugs Market, 2017-2030 (US$ Bn)

List of Tables
TABLE 1 Market Snapshot: Global Mesoporous silica nanoparticles drugs Market
TABLE 2 Global Mesoporous silica nanoparticles drugs Market: Market Drivers Impact Analysis
TABLE 3 Global Mesoporous silica nanoparticles drugs Market: Market Restraints Impact Analysis
TABLE 4 Global Mesoporous silica nanoparticles drugs Market, by Competitive Benchmarking, 2022
TABLE 5 Global Mesoporous silica nanoparticles drugs Market, by Geographical Presence Analysis, 2022
TABLE 6 Global Mesoporous silica nanoparticles drugs Market, by Key Strategies Analysis, 2022
TABLE 7 Global Mesoporous silica nanoparticles drugs Market, by Pharmaceutical Company, By Region, 2017-2022 (US$ Bn)
TABLE 8 Global Mesoporous silica nanoparticles drugs Market, by Pharmaceutical Company, By Region, 2023-2030 (US$ Bn)
TABLE 9 Global Mesoporous silica nanoparticles drugs Market, by Biotechnology companies, By Region, 2017-2022 (US$ Bn)
TABLE 10 Global Mesoporous silica nanoparticles drugs Market, by Biotechnology companies, By Region, 2023-2030 (US$ Bn)
TABLE 11 Global Mesoporous silica nanoparticles drugs Market, by Academic and research institutions, By Region, 2017-2022 (US$ Bn)
TABLE 12 Global Mesoporous silica nanoparticles drugs Market, by Academic and research institutions, By Region, 2023-2030 (US$ Bn)
TABLE 13 Global Mesoporous silica nanoparticles drugs Market, by Others, By Region, 2017-2022 (US$ Bn)
TABLE 14 Global Mesoporous silica nanoparticles drugs Market, by Others, By Region, 2023-2030 (US$ Bn)
TABLE 15 Global Mesoporous silica nanoparticles drugs Market, by small molecules, By Region, 2017-2022 (US$ Bn)
TABLE 16 Global Mesoporous silica nanoparticles drugs Market, by small molecules, By Region, 2023-2030 (US$ Bn)
TABLE 17 Global Mesoporous silica nanoparticles drugs Market, by Peptides, By Region, 2017-2022 (US$ Bn)
TABLE 18 Global Mesoporous silica nanoparticles drugs Market, by Peptides, By Region, 2023-2030 (US$ Bn)
TABLE 19 Global Mesoporous silica nanoparticles drugs Market, by Proteins, By Region, 2017-2022 (US$ Bn)
TABLE 20 Global Mesoporous silica nanoparticles drugs Market, by Proteins, By Region, 2023-2030 (US$ Bn)
TABLE 21 Global Mesoporous silica nanoparticles drugs Market, by Nucleic acids, By Region, 2017-2022 (US$ Bn)
TABLE 22 Global Mesoporous silica nanoparticles drugs Market, by Nucleic acids, By Region, 2023-2030 (US$ Bn)
TABLE 23 Global Mesoporous silica nanoparticles drugs Market, by Others (Essential Oils, Floral Flavours), By Region, 2017-2022 (US$ Bn)
TABLE 24 Global Mesoporous silica nanoparticles drugs Market, by Others (Essential Oils, Floral Flavours), By Region, 2023-2030 (US$ Bn)
TABLE 25 Global Mesoporous silica nanoparticles drugs Market, by Cancer therapy, By Region, 2017-2022 (US$ Bn)
TABLE 26 Global Mesoporous silica nanoparticles drugs Market, by Cancer therapy, By Region, 2023-2030 (US$ Bn)
TABLE 27 Global Mesoporous silica nanoparticles drugs Market, by Cardiovascular disease, By Region, 2017-2022 (US$ Bn)
TABLE 28 Global Mesoporous silica nanoparticles drugs Market, by Cardiovascular disease, By Region, 2023-2030 (US$ Bn)
TABLE 29 Global Mesoporous silica nanoparticles drugs Market, by Neurological disorders, By Region, 2017-2022 (US$ Bn)
TABLE 30 Global Mesoporous silica nanoparticles drugs Market, by Neurological disorders, By Region, 2023-2030 (US$ Bn)
TABLE 31 Global Mesoporous silica nanoparticles drugs Market, by Others, By Region, 2017-2022 (US$ Bn)
TABLE 32 Global Mesoporous silica nanoparticles drugs Market, by Others, By Region, 2023-2030 (US$ Bn)
TABLE 33 Global Mesoporous silica nanoparticles drugs Market, by End-user, 2017-2022 (US$ Bn)
TABLE 34 Global Mesoporous silica nanoparticles drugs Market, by End-user, 2023-2030 (US$ Bn)
TABLE 35 Global Mesoporous silica nanoparticles drugs Market, by Type, 2017-2022 (US$ Bn)
TABLE 36 Global Mesoporous silica nanoparticles drugs Market, by Type, 2023-2030 (US$ Bn)
TABLE 37 Global Mesoporous silica nanoparticles drugs Market, by Application, 2017-2022 (US$ Bn)
TABLE 38 Global Mesoporous silica nanoparticles drugs Market, by Application, 2023-2030 (US$ Bn)
TABLE 39 Global Mesoporous silica nanoparticles drugs Market, by Region, 2017-2022 (US$ Bn)
TABLE 40 Global Mesoporous silica nanoparticles drugs Market, by Region, 2023-2030 (US$ Bn)
TABLE 41 North America Mesoporous silica nanoparticles drugs Market, by End-user, 2017-2022 (US$ Bn)
TABLE 42 North America Mesoporous silica nanoparticles drugs Market, by End-user, 2023-2030 (US$ Bn)
TABLE 43 North America Mesoporous silica nanoparticles drugs Market, by Type, 2017-2022 (US$ Bn)
TABLE 44 North America Mesoporous silica nanoparticles drugs Market, by Type, 2023-2030 (US$ Bn)
TABLE 45 North America Mesoporous silica nanoparticles drugs Market, by Application, 2017-2022 (US$ Bn)
TABLE 46 North America Mesoporous silica nanoparticles drugs Market, by Application, 2023-2030 (US$ Bn)
TABLE 47 North America Mesoporous silica nanoparticles drugs Market, by Country, 2017-2022 (US$ Bn)
TABLE 48 North America Mesoporous silica nanoparticles drugs Market, by Country, 2023-2030 (US$ Bn)
TABLE 49 United States Mesoporous silica nanoparticles drugs Market, by End-user, 2017-2022 (US$ Bn)
TABLE 50 United States Mesoporous silica nanoparticles drugs Market, by End-user, 2023-2030 (US$ Bn)
TABLE 51 United States Mesoporous silica nanoparticles drugs Market, by Type, 2017-2022 (US$ Bn)
TABLE 52 United States Mesoporous silica nanoparticles drugs Market, by Type, 2023-2030 (US$ Bn)
TABLE 53 United States Mesoporous silica nanoparticles drugs Market, by Application, 2017-2022 (US$ Bn)
TABLE 54 United States Mesoporous silica nanoparticles drugs Market, by Application, 2023-2030 (US$ Bn)
TABLE 55 Canada Mesoporous silica nanoparticles drugs Market, by End-user, 2017-2022 (US$ Bn)
TABLE 56 Canada Mesoporous silica nanoparticles drugs Market, by End-user, 2023-2030 (US$ Bn)
TABLE 57 Canada Mesoporous silica nanoparticles drugs Market, by Type, 2017-2022 (US$ Bn)
TABLE 58 Canada Mesoporous silica nanoparticles drugs Market, by Type, 2023-2030 (US$ Bn)
TABLE 59 Canada Mesoporous silica nanoparticles drugs Market, by Application, 2017-2022 (US$ Bn)
TABLE 60 Canada Mesoporous silica nanoparticles drugs Market, by Application, 2023-2030 (US$ Bn)
TABLE 61 Mexico Mesoporous silica nanoparticles drugs Market, by End-user, 2017-2022 (US$ Bn)
TABLE 62 Mexico Mesoporous silica nanoparticles drugs Market, by End-user, 2023-2030 (US$ Bn)
TABLE 63 Mexico Mesoporous silica nanoparticles drugs Market, by Type, 2017-2022 (US$ Bn)
TABLE 64 Mexico Mesoporous silica nanoparticles drugs Market, by Type, 2023-2030 (US$ Bn)
TABLE 65 Mexico Mesoporous silica nanoparticles drugs Market, by Application, 2017-2022 (US$ Bn)
TABLE 66 Mexico Mesoporous silica nanoparticles drugs Market, by Application, 2023-2030 (US$ Bn)
TABLE 67 Europe Mesoporous silica nanoparticles drugs Market, by End-user, 2017-2022 (US$ Bn)
TABLE 68 Europe Mesoporous silica nanoparticles drugs Market, by End-user, 2023-2030 (US$ Bn)
TABLE 69 Europe Mesoporous silica nanoparticles drugs Market, by Type, 2017-2022 (US$ Bn)
TABLE 70 Europe Mesoporous silica nanoparticles drugs Market, by Type, 2023-2030 (US$ Bn)
TABLE 71 Europe Mesoporous silica nanoparticles drugs Market, by Application, 2017-2022 (US$ Bn)
TABLE 72 Europe Mesoporous silica nanoparticles drugs Market, by Application, 2023-2030 (US$ Bn)
TABLE 73 Europe Mesoporous silica nanoparticles drugs Market, by Country, 2017-2022 (US$ Bn)
TABLE 74 Europe Mesoporous silica nanoparticles drugs Market, by Country, 2023-2030 (US$ Bn)
TABLE 75 Germany Mesoporous silica nanoparticles drugs Market, by End-user, 2017-2022 (US$ Bn)
TABLE 76 Germany Mesoporous silica nanoparticles drugs Market, by End-user, 2023-2030 (US$ Bn)
TABLE 77 Germany Mesoporous silica nanoparticles drugs Market, by Type, 2017-2022 (US$ Bn)
TABLE 78 Germany Mesoporous silica nanoparticles drugs Market, by Type, 2023-2030 (US$ Bn)
TABLE 79 Germany Mesoporous silica nanoparticles drugs Market, by Application, 2017-2022 (US$ Bn)
TABLE 80 Germany Mesoporous silica nanoparticles drugs Market, by Application, 2023-2030 (US$ Bn)
TABLE 81 France Mesoporous silica nanoparticles drugs Market, by End-user, 2017-2022 (US$ Bn)
TABLE 82 France Mesoporous silica nanoparticles drugs Market, by End-user, 2023-2030 (US$ Bn)
TABLE 83 France Mesoporous silica nanoparticles drugs Market, by Type, 2017-2022 (US$ Bn)
TABLE 84 France Mesoporous silica nanoparticles drugs Market, by Type, 2023-2030 (US$ Bn)
TABLE 85 France Mesoporous silica nanoparticles drugs Market, by Application, 2017-2022 (US$ Bn)
TABLE 86 France Mesoporous silica nanoparticles drugs Market, by Application, 2023-2030 (US$ Bn)
TABLE 87 United Kingdom Mesoporous silica nanoparticles drugs Market, by End-user, 2017-2022 (US$ Bn)
TABLE 88 United Kingdom Mesoporous silica nanoparticles drugs Market, by End-user, 2023-2030 (US$ Bn)
TABLE 89 United Kingdom Mesoporous silica nanoparticles drugs Market, by Type, 2017-2022 (US$ Bn)
TABLE 90 United Kingdom Mesoporous silica nanoparticles drugs Market, by Type, 2023-2030 (US$ Bn)
TABLE 91 United Kingdom Mesoporous silica nanoparticles drugs Market, by Application, 2017-2022 (US$ Bn)
TABLE 92 United Kingdom Mesoporous silica nanoparticles drugs Market, by Application, 2023-2030 (US$ Bn)
TABLE 93 Italy Mesoporous silica nanoparticles drugs Market, by End-user, 2017-2022 (US$ Bn)
TABLE 94 Italy Mesoporous silica nanoparticles drugs Market, by End-user, 2023-2030 (US$ Bn)
TABLE 95 Italy Mesoporous silica nanoparticles drugs Market, by Type, 2017-2022 (US$ Bn)
TABLE 96 Italy Mesoporous silica nanoparticles drugs Market, by Type, 2023-2030 (US$ Bn)
TABLE 97 Italy Mesoporous silica nanoparticles drugs Market, by Application, 2017-2022 (US$ Bn)
TABLE 98 Italy Mesoporous silica nanoparticles drugs Market, by Application, 2023-2030 (US$ Bn)
TABLE 99 Spain Mesoporous silica nanoparticles drugs Market, by End-user, 2017-2022 (US$ Bn)
TABLE 100 Spain Mesoporous silica nanoparticles drugs Market, by End-user, 2023-2030 (US$ Bn)
TABLE 101 Spain Mesoporous silica nanoparticles drugs Market, by Type, 2017-2022 (US$ Bn)
TABLE 102 Spain Mesoporous silica nanoparticles drugs Market, by Type, 2023-2030 (US$ Bn)
TABLE 103 Spain Mesoporous silica nanoparticles drugs Market, by Application, 2017-2022 (US$ Bn)
TABLE 104 Spain Mesoporous silica nanoparticles drugs Market, by Application, 2023-2030 (US$ Bn)
TABLE 105 Rest of Europe Mesoporous silica nanoparticles drugs Market, by End-user, 2017-2022 (US$ Bn)
TABLE 106 Rest of Europe Mesoporous silica nanoparticles drugs Market, by End-user, 2023-2030 (US$ Bn)
TABLE 107 Rest of Europe Mesoporous silica nanoparticles drugs Market, by Type, 2017-2022 (US$ Bn)
TABLE 108 Rest of Europe Mesoporous silica nanoparticles drugs Market, by Application, 2023-2030 (US$ Bn)
TABLE 109 Rest of Europe Mesoporous silica nanoparticles drugs Market, by Application, 2017-2022 (US$ Bn)
TABLE 110 Rest of Europe Mesoporous silica nanoparticles drugs Market, by Type, 2023-2030 (US$ Bn)
TABLE 111 Asia Pacific Mesoporous silica nanoparticles drugs Market, by End-user, 2017-2022 (US$ Bn)
TABLE 112 Asia Pacific Mesoporous silica nanoparticles drugs Market, by End-user, 2023-2030 (US$ Bn)
TABLE 113 Asia Pacific Mesoporous silica nanoparticles drugs Market, by Type, 2017-2022 (US$ Bn)
TABLE 114 Asia Pacific Mesoporous silica nanoparticles drugs Market, by Type, 2023-2030 (US$ Bn)
TABLE 115 Asia Pacific Mesoporous silica nanoparticles drugs Market, by Application, 2017-2022 (US$ Bn)
TABLE 116 Asia Pacific Mesoporous silica nanoparticles drugs Market, by Application, 2023-2030 (US$ Bn)
TABLE 117 Asia Pacific Mesoporous silica nanoparticles drugs Market, by Country, 2017-2022 (US$ Bn)
TABLE 118 Asia Pacific Mesoporous silica nanoparticles drugs Market, by Country, 2023-2030 (US$ Bn)
TABLE 119 China Mesoporous silica nanoparticles drugs Market, by End-user, 2017-2022 (US$ Bn)
TABLE 120 China Mesoporous silica nanoparticles drugs Market, by End-user, 2023-2030 (US$ Bn)
TABLE 121 China Mesoporous silica nanoparticles drugs Market, by Type, 2017-2022 (US$ Bn)
TABLE 122 China Mesoporous silica nanoparticles drugs Market, by Type, 2023-2030 (US$ Bn)
TABLE 123 China Mesoporous silica nanoparticles drugs Market, by Application, 2017-2022 (US$ Bn)
TABLE 124 China Mesoporous silica nanoparticles drugs Market, by Application, 2023-2030 (US$ Bn)
TABLE 125 Japan Mesoporous silica nanoparticles drugs Market, by End-user, 2017-2022 (US$ Bn)
TABLE 126 Japan Mesoporous silica nanoparticles drugs Market, by End-user, 2023-2030 (US$ Bn)
TABLE 127 Japan Mesoporous silica nanoparticles drugs Market, by Type, 2017-2022 (US$ Bn)
TABLE 128 Japan Mesoporous silica nanoparticles drugs Market, by Type, 2023-2030 (US$ Bn)
TABLE 129 Japan Mesoporous silica nanoparticles drugs Market, by Application, 2017-2022 (US$ Bn)
TABLE 130 Japan Mesoporous silica nanoparticles drugs Market, by Application, 2023-2030 (US$ Bn)
TABLE 131 India Mesoporous silica nanoparticles drugs Market, by End-user, 2017-2022 (US$ Bn)
TABLE 132 India Mesoporous silica nanoparticles drugs Market, by End-user, 2023-2030 (US$ Bn)
TABLE 133 India Mesoporous silica nanoparticles drugs Market, by Type, 2017-2022 (US$ Bn)
TABLE 134 India Mesoporous silica nanoparticles drugs Market, by Type, 2023-2030 (US$ Bn)
TABLE 135 India Mesoporous silica nanoparticles drugs Market, by Application, 2017-2022 (US$ Bn)
TABLE 136 India Mesoporous silica nanoparticles drugs Market, by Application, 2023-2030 (US$ Bn)
TABLE 137 South Korea Mesoporous silica nanoparticles drugs Market, by End-user, 2017-2022 (US$ Bn)
TABLE 138 South Korea Mesoporous silica nanoparticles drugs Market, by End-user, 2023-2030 (US$ Bn)
TABLE 139 South Korea Mesoporous silica nanoparticles drugs Market, by Type, 2017-2022 (US$ Bn)
TABLE 140 South Korea Mesoporous silica nanoparticles drugs Market, by Type, 2023-2030 (US$ Bn)
TABLE 141 South Korea Mesoporous silica nanoparticles drugs Market, by Application, 2017-2022 (US$ Bn)
TABLE 142 South Korea Mesoporous silica nanoparticles drugs Market, by Application, 2023-2030 (US$ Bn)
TABLE 143 South-East Asia Mesoporous silica nanoparticles drugs Market, by End-user, 2017-2022 (US$ Bn)
TABLE 144 South-East Asia Mesoporous silica nanoparticles drugs Market, by End-user, 2023-2030 (US$ Bn)
TABLE 145 South-East Asia Mesoporous silica nanoparticles drugs Market, by Type, 2017-2022 (US$ Bn)
TABLE 146 South-East Asia Mesoporous silica nanoparticles drugs Market, by Type, 2023-2030 (US$ Bn)
TABLE 147 South-East Asia Mesoporous silica nanoparticles drugs Market, by Application, 2017-2022 (US$ Bn)
TABLE 148 South-East Asia Mesoporous silica nanoparticles drugs Market, by Application, 2023-2030 (US$ Bn)
TABLE 149 Rest of Asia Pacific Mesoporous silica nanoparticles drugs Market, by End-user, 2017-2022 (US$ Bn)
TABLE 150 Rest of Asia Pacific Mesoporous silica nanoparticles drugs Market, by End-user, 2023-2030 (US$ Bn)
TABLE 151 Rest of Asia Pacific Mesoporous silica nanoparticles drugs Market, by Type, 2017-2022 (US$ Bn)
TABLE 152 Rest of Asia Pacific Mesoporous silica nanoparticles drugs Market, by Type, 2023-2030 (US$ Bn)
TABLE 153 Rest of Asia Pacific Mesoporous silica nanoparticles drugs Market, by Application, 2017-2022 (US$ Bn)
TABLE 154 Rest of Asia Pacific Mesoporous silica nanoparticles drugs Market, by Application, 2023-2030 (US$ Bn)
TABLE 155 Latin America Mesoporous silica nanoparticles drugs Market, by End-user, 2017-2022 (US$ Bn)
TABLE 156 Latin America Mesoporous silica nanoparticles drugs Market, by End-user, 2023-2030 (US$ Bn)
TABLE 157 Latin America Mesoporous silica nanoparticles drugs Market, by Type, 2017-2022 (US$ Bn)
TABLE 158 Latin America Mesoporous silica nanoparticles drugs Market, by Type, 2023-2030 (US$ Bn)
TABLE 159 Latin America Mesoporous silica nanoparticles drugs Market, by Application, 2017-2022 (US$ Bn)
TABLE 160 Latin America Mesoporous silica nanoparticles drugs Market, by Application, 2023-2030 (US$ Bn)
TABLE 161 Latin America Mesoporous silica nanoparticles drugs Market, by Country, 2017-2022 (US$ Bn)
TABLE 162 Latin America Mesoporous silica nanoparticles drugs Market, by Country, 2023-2030 (US$ Bn)
TABLE 163 Brazil Mesoporous silica nanoparticles drugs Market, by End-user, 2017-2022 (US$ Bn)
TABLE 164 Brazil Mesoporous silica nanoparticles drugs Market, by End-user, 2023-2030 (US$ Bn)
TABLE 165 Brazil Mesoporous silica nanoparticles drugs Market, by Type, 2017-2022 (US$ Bn)
TABLE 166 Brazil Mesoporous silica nanoparticles drugs Market, by Type, 2023-2030 (US$ Bn)
TABLE 167 Brazil Mesoporous silica nanoparticles drugs Market, by Application, 2017-2022 (US$ Bn)
TABLE 168 Brazil Mesoporous silica nanoparticles drugs Market, by Application, 2023-2030 (US$ Bn)
TABLE 169 Argentina Mesoporous silica nanoparticles drugs Market, by End-user, 2017-2022 (US$ Bn)
TABLE 170 Argentina Mesoporous silica nanoparticles drugs Market, by End-user, 2023-2030 (US$ Bn)
TABLE 171 Argentina Mesoporous silica nanoparticles drugs Market, by Type, 2017-2022 (US$ Bn)
TABLE 172 Argentina Mesoporous silica nanoparticles drugs Market, by Type, 2023-2030 (US$ Bn)
TABLE 173 Argentina Mesoporous silica nanoparticles drugs Market, by Application, 2017-2022 (US$ Bn)
TABLE 174 Argentina Mesoporous silica nanoparticles drugs Market, by Application, 2023-2030 (US$ Bn)
TABLE 175 Rest of Latin America Mesoporous silica nanoparticles drugs Market, by End-user, 2017-2022 (US$ Bn)
TABLE 176 Rest of Latin America Mesoporous silica nanoparticles drugs Market, by End-user, 2023-2030 (US$ Bn)
TABLE 177 Rest of Latin America Mesoporous silica nanoparticles drugs Market, by Type, 2017-2022 (US$ Bn)
TABLE 178 Rest of Latin America Mesoporous silica nanoparticles drugs Market, by Type, 2023-2030 (US$ Bn)
TABLE 179 Rest of Latin America Mesoporous silica nanoparticles drugs Market, by Application, 2017-2022 (US$ Bn)
TABLE 180 Rest of Latin America Mesoporous silica nanoparticles drugs Market, by Application, 2023-2030 (US$ Bn)
TABLE 181 Middle East and Africa Mesoporous silica nanoparticles drugs Market, by End-user, 2017-2022 (US$ Bn)
TABLE 182 Middle East and Africa Mesoporous silica nanoparticles drugs Market, by End-user, 2023-2030 (US$ Bn)
TABLE 183 Middle East and Africa Mesoporous silica nanoparticles drugs Market, by Type, 2017-2022 (US$ Bn)
TABLE 184 Middle East and Africa Mesoporous silica nanoparticles drugs Market, by Type, 2023-2030 (US$ Bn)
TABLE 185 Middle East and Africa Mesoporous silica nanoparticles drugs Market, by Application, 2017-2022 (US$ Bn)
TABLE 186 Middle East and Africa Mesoporous silica nanoparticles drugs Market, by Application, 2023-2030 (US$ Bn)
TABLE 187 Middle East and Africa Mesoporous silica nanoparticles drugs Market, by Country, 2017-2022 (US$ Bn)
TABLE 188 Middle East and Africa Mesoporous silica nanoparticles drugs Market, by Country, 2023-2030 (US$ Bn)
TABLE 189 GCC Countries Mesoporous silica nanoparticles drugs Market, by End-user, 2017-2022 (US$ Bn)
TABLE 190 GCC Countries Mesoporous silica nanoparticles drugs Market, by End-user, 2023-2030 (US$ Bn)
TABLE 191 GCC Countries Mesoporous silica nanoparticles drugs Market, by Type, 2017-2022 (US$ Bn)
TABLE 192 GCC Countries Mesoporous silica nanoparticles drugs Market, by Type, 2023-2030 (US$ Bn)
TABLE 193 GCC Countries Mesoporous silica nanoparticles drugs Market, by Application, 2017-2022 (US$ Bn)
TABLE 194 GCC Countries Mesoporous silica nanoparticles drugs Market, by Application, 2023-2030 (US$ Bn)
TABLE 195 South Africa Mesoporous silica nanoparticles drugs Market, by End-user, 2017-2022 (US$ Bn)
TABLE 196 South Africa Mesoporous silica nanoparticles drugs Market, by End-user, 2023-2030 (US$ Bn)
TABLE 197 South Africa Mesoporous silica nanoparticles drugs Market, by Type, 2017-2022 (US$ Bn)
TABLE 198 South Africa Mesoporous silica nanoparticles drugs Market, by Type, 2023-2030 (US$ Bn)
TABLE 199 South Africa Mesoporous silica nanoparticles drugs Market, by Application, 2017-2022 (US$ Bn)
TABLE 200 South Africa Mesoporous silica nanoparticles drugs Market, by Application, 2023-2030 (US$ Bn)
TABLE 201 Rest of Middle East and Africa Mesoporous silica nanoparticles drugs Market, by End-user, 2017-2022 (US$ Bn)
TABLE 202 Rest of Middle East and Africa Mesoporous silica nanoparticles drugs Market, by End-user, 2023-2030 (US$ Bn)
TABLE 203 Rest of Middle East and Africa Mesoporous silica nanoparticles drugs Market, by Type, 2017-2022 (US$ Bn)
TABLE 204 Rest of Middle East and Africa Mesoporous silica nanoparticles drugs Market, by Type, 2023-2030 (US$ Bn)
TABLE 205 Rest of Middle East and Africa Mesoporous silica nanoparticles drugs Market, by Application, 2017-2022 (US$ Bn)
TABLE 206 Rest of Middle East and Africa Mesoporous silica nanoparticles drugs Market, by Application, 2023-2030 (US$ Bn)

Frequently Asked Questions

What is the current size of the global mesoporous silica nanoparticles drugs market?

The global Mesoporous silica nanoparticles drugs market was valued at USD XX Billion in 2022.

What is the expected growth rate of the Mesoporous silica nanoparticles drugs market between 2023 and 2030?

The Mesoporous silica nanoparticles drugs market is expected to grow at a CAGR of 8.90% between 2023 and 2030, reaching USD XX Billion in 2030.

Which end-user segment is leading the market share in terms of End-user?

Pharmaceutical company is the leading segment by the end-user, holding more than three-firth of the share in value in 2022.

Which application governs the demand for Mesoporous silica nanoparticle drugs in the world?

Cancer therapy governs the demand for Mesoporous silica nanoparticle drugs worldwide, holding a massive share of nearly 35% in 2022.

Which segment is expected to post the highest CAGR during the forecast period?

Biotechnology companies & other segments are expected to post the highest CAGR during the forecast period.

Which region is fueling the growth of the Mesoporous silica nanoparticles drugs industry?

Asia-pacific is fueling the growth of the Mesoporous silica nanoparticles drugs industry, with nearly a two-thirds share in 2022.

Who are the major players in the global Mesoporous silica nanoparticles drugs market?

The top players include Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., FUJIFILM Wako Pure Chemical Corporation, Merck KGaA, Novo Nordisk A/S, Shimadzu Corporation, Sigma-Aldrich Corporation, Suzhou Pole-Star Polymer Material Co., Ltd., Thermo Fisher Scientific, and Waters Corporation, and others.

What is the major market driver of the mesoporous silica nanoparticles drugs industry?

Increasing prevalence of chronic diseases such as cancer and cardiovascular disorders & growing emphasis on personalized medicine and precision therapeutics are the major market drivers.

What are the major market restraints of the mesoporous silica nanoparticles drugs industry?

Stringent regulatory requirements for the approval of novel drug delivery systems & high cost associated with the development and production of MSN drugs limit their accessibility and are still restraints of the mesoporous silica nanoparticles drugs industry.

What are the major market opportunities of the mesoporous silica nanoparticles drugs industry?

Growing focus on personalized medicine and targeted therapies & advancements in nanotechnology and material science provide scope for the development of innovative MSN formulations with improved properties are opportunities for the mesoporous silica nanoparticles drugs industry.

Purchase Options

Request Free Sample

Have a question?

Don’t settle for less – trust Mitul to help you find the best solution.

Call: +91 6232 49 3207

EMAIL MITUL

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –